Celsius Holdings, Inc. (NASDAQ:CELH – Free Report) – Investment analysts at Roth Capital lowered their FY2024 EPS estimates for Celsius in a note issued to investors on Monday, December 16th. Roth Capital analyst S. Mcgowan now expects that the company will earn $0.67 per share for the year, down from their prior forecast of $0.71. The consensus estimate for Celsius’ current full-year earnings is $0.69 per share. Roth Capital also issued estimates for Celsius’ Q4 2024 earnings at $0.12 EPS, Q4 2025 earnings at $0.21 EPS, FY2025 earnings at $0.87 EPS and FY2026 earnings at $1.06 EPS.
Several other research analysts have also recently weighed in on CELH. Piper Sandler lowered their target price on Celsius from $50.00 to $47.00 and set an “overweight” rating on the stock in a report on Tuesday, September 24th. Deutsche Bank Aktiengesellschaft started coverage on Celsius in a report on Thursday, December 12th. They issued a “hold” rating and a $32.00 target price for the company. LADENBURG THALM/SH SH reduced their price target on Celsius from $72.00 to $68.00 and set a “neutral” rating on the stock in a report on Monday, October 21st. B. Riley lowered their price target on shares of Celsius from $50.00 to $47.00 and set a “buy” rating on the stock in a research report on Monday, November 4th. Finally, Maxim Group cut their price objective on shares of Celsius from $65.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday, September 5th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $50.72.
Celsius Trading Down 7.4 %
Shares of NASDAQ CELH opened at $27.09 on Tuesday. The stock has a market cap of $6.37 billion, a PE ratio of 37.63, a P/E/G ratio of 3.44 and a beta of 1.76. Celsius has a 12-month low of $25.23 and a 12-month high of $99.62. The company has a 50-day moving average of $30.03 and a 200 day moving average of $40.38.
Insider Buying and Selling
In related news, major shareholder William H. Milmoe sold 65,000 shares of the business’s stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $31.15, for a total transaction of $2,024,750.00. Following the completion of the transaction, the insider now owns 261,245 shares in the company, valued at approximately $8,137,781.75. The trade was a 19.92 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 2.20% of the stock is owned by insiders.
Institutional Trading of Celsius
A number of institutional investors have recently bought and sold shares of the business. Benjamin F. Edwards & Company Inc. raised its position in shares of Celsius by 353.1% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 648 shares of the company’s stock worth $37,000 after acquiring an additional 505 shares in the last quarter. Newbridge Financial Services Group Inc. increased its stake in Celsius by 3,150.0% in the second quarter. Newbridge Financial Services Group Inc. now owns 650 shares of the company’s stock valued at $37,000 after purchasing an additional 630 shares during the last quarter. Itau Unibanco Holding S.A. acquired a new stake in Celsius during the second quarter worth approximately $45,000. PrairieView Partners LLC purchased a new stake in shares of Celsius during the 2nd quarter worth approximately $57,000. Finally, Crewe Advisors LLC acquired a new position in shares of Celsius in the 2nd quarter valued at $63,000. 60.95% of the stock is owned by hedge funds and other institutional investors.
Celsius Company Profile
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Further Reading
- Five stocks we like better than Celsius
- Airline Stocks – Top Airline Stocks to Buy Now
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What is a Stock Market Index and How Do You Use Them?
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- How to Use Stock Screeners to Find Stocks
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.